Astria Therapeutics Inc (ATXS)
9.55
+0.20
(+2.14%)
USD |
NASDAQ |
May 03, 16:00
9.55
0.00 (0.00%)
Pre-Market: 20:00
Astria Therapeutics Price to Book Value: 3.548 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 3.548 |
| May 02, 2024 | 3.473 |
| May 01, 2024 | 3.529 |
| April 30, 2024 | 3.410 |
| April 29, 2024 | 3.399 |
| April 26, 2024 | 3.343 |
| April 25, 2024 | 3.407 |
| April 24, 2024 | 3.343 |
| April 23, 2024 | 3.581 |
| April 22, 2024 | 3.641 |
| April 19, 2024 | 3.622 |
| April 18, 2024 | 3.916 |
| April 17, 2024 | 3.919 |
| April 16, 2024 | 4.124 |
| April 15, 2024 | 4.046 |
| April 12, 2024 | 4.016 |
| April 11, 2024 | 4.183 |
| April 10, 2024 | 4.150 |
| April 09, 2024 | 4.268 |
| April 08, 2024 | 4.235 |
| April 05, 2024 | 4.187 |
| April 04, 2024 | 4.287 |
| April 03, 2024 | 4.495 |
| April 02, 2024 | 4.755 |
| April 01, 2024 | 5.019 |
| Date | Value |
|---|---|
| March 28, 2024 | 5.229 |
| March 27, 2024 | 5.052 |
| March 26, 2024 | 5.026 |
| March 25, 2024 | 5.480 |
| March 22, 2024 | 5.621 |
| March 21, 2024 | 5.940 |
| March 20, 2024 | 5.840 |
| March 19, 2024 | 6.200 |
| March 18, 2024 | 5.799 |
| March 15, 2024 | 5.743 |
| March 14, 2024 | 5.428 |
| March 13, 2024 | 5.572 |
| March 12, 2024 | 5.379 |
| March 11, 2024 | 5.398 |
| March 08, 2024 | 5.331 |
| March 07, 2024 | 5.424 |
| March 06, 2024 | 5.461 |
| March 05, 2024 | 5.145 |
| March 04, 2024 | 5.297 |
| March 01, 2024 | 5.565 |
| February 29, 2024 | 5.283 |
| February 28, 2024 | 5.522 |
| February 27, 2024 | 5.171 |
| February 26, 2024 | 5.219 |
| February 23, 2024 | 4.768 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5376
Minimum
Nov 06 2020
51.00
Maximum
Sep 20 2022
4.48
Average
2.471
Median
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.094 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.7539 |
| Theriva Biologics Inc | 0.187 |
| Oragenics Inc | 3.043 |
Price to Book Value Related Metrics
| Price | 9.55 |
| Earnings Yield | -25.34% |
| Market Cap | 524.32M |